Tutorials
Opiant Pharmaceuticals Inc logo

Opiant Pharmaceuticals Inc

$ 11.90 +0.06 (+0.51%) 08:08 PM EST
P/E:
At Loss
P/B:
1.54
Market Cap:
$ 60.53M
Enterprise V:
$ 23.96M
Volume:
9.09K
Avg Vol (2M):
22.00K
Also Trade In:
Volume:
9.09K
Market Cap $:
60.53M
PE Ratio:
At Loss
Avg Vol (2-Month):
22.00K
Enterprise Value $:
23.96M
PB Ratio:
1.54
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download Tutorials

Business Description

Opiant Pharmaceuticals Inc
NAICS : 325412 SIC : 2834
233 Wilshire Boulevard, Suite 280, Santa Monica, CA, USA, 90401
Description
Opiant Pharmaceuticals Inc is a specialty pharmaceutical company operating in the US. It develops pharmacological treatments for substance use, addictive and eating disorders. The company has developed NARCAN, a Nasal Spray for treatment to reverse opioid overdoses. The company's pipeline includes medicines in development for Opioid Overdose Reversal (OOR), Alcohol Use Disorder (AUD), Opioid Use Disorder (OUD) and Acute Cannabinoid Overdose (ACO). The majority of the revenue is generated in the form of Royalty and licensing.
Name Current Vs Industry Vs History
Cash-To-Debt 3.49
Equity-to-Asset 0.65
Debt-to-Equity 0.37
Debt-to-EBITDA -3.98
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 1.45
Distress
Grey
Safe
Beneish M-Score -3.08
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
3-Year Revenue Growth Rate 15
3-Year Book Growth Rate 29.6
Name Current Vs Industry Vs History
5-Day RSI 82.25
9-Day RSI 68.81
14-Day RSI 57.98
6-1 Month Momentum % -53.21
12-1 Month Momentum % -26.5

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 8.72
Quick Ratio 8.72
Cash Ratio 7.49
Days Sales Outstanding 91.84
Days Payable 149.18

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -8.5

Financials (Next Earnings Date:2022-08-11)

OPNT's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Gurus Latest Trades with NAS:OPNT

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

EMBED

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 38.584
EPS (TTM) ($) -1.46
Beta 0.72
Volatility % 82.94
14-Day RSI 57.98
14-Day ATR ($) 0.781178
20-Day SMA ($) 10.838
12-1 Month Momentum % -26.5
52-Week Range ($) 7.34 - 37.7114
Shares Outstanding (Mil) 5.09

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Opiant Pharmaceuticals Inc Filings

Document Form Filing Date
No Filing Data

Headlines

See More